Citation
Liu, Chun-Wei, et al. "Rosuvastatin Postconditioning Protects Isolated Hearts Against Ischemia-reperfusion Injury: the Role of Radical Oxygen Species, PI3K-Akt-GSK-3β Pathway, and Mitochondrial Permeability Transition Pore." Cardiovascular Therapeutics, vol. 35, no. 1, 2017, pp. 3-9.
Liu CW, Yang F, Cheng SZ, et al. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore. Cardiovasc Ther. 2017;35(1):3-9.
Liu, C. W., Yang, F., Cheng, S. Z., Liu, Y., Wan, L. H., & Cong, H. L. (2017). Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore. Cardiovascular Therapeutics, 35(1), 3-9. https://doi.org/10.1111/1755-5922.12225
Liu CW, et al. Rosuvastatin Postconditioning Protects Isolated Hearts Against Ischemia-reperfusion Injury: the Role of Radical Oxygen Species, PI3K-Akt-GSK-3β Pathway, and Mitochondrial Permeability Transition Pore. Cardiovasc Ther. 2017;35(1):3-9. PubMed PMID: 27580017.
TY - JOUR
T1 - Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
AU - Liu,Chun-Wei,
AU - Yang,Fan,
AU - Cheng,Shi-Zhao,
AU - Liu,Yue,
AU - Wan,Liang-Hui,
AU - Cong,Hong-Liang,
PY - 2015/09/27/received
PY - 2016/05/04/revised
PY - 2016/08/26/accepted
PY - 2016/9/1/pubmed
PY - 2017/2/14/medline
PY - 2016/9/1/entrez
KW - ROS
KW - GSK-3β
KW - MPTP opening
KW - PI3K-Akt
KW - Rosuvastatin
SP - 3
EP - 9
JF - Cardiovascular therapeutics
JO - Cardiovasc Ther
VL - 35
IS - 1
N2 - AIMS: Glycogen synthase kinase-3β (GSK-3β) and mitochondrial permeability transition pore (mPTP) play an important role in myocardial ischemia-reperfusion injury. The aim of this study was to investigate whether postconditioning with rosuvastatin is able to reduce myocardial ischemia-reperfusion injury and clarify the potential mechanisms. METHODS: Isolated rat hearts underwent 30 minutes of ischemia and 60 minutes of reperfusion in the presence or absence of rosuvastatin (1-50 nmol/L). The activity of signaling pathway was determined by Western blot analysis, and Ca2+ -induced mPTP opening was assessed by the use of a potentiometric method. RESULTS: Rosuvastatin significantly reduced myocardial infarct size and improved cardiac function at 5 and 10 nmol/L. Protection disappeared at higher concentration and reverted to increased damage at 50 nmol/L. At 5 nmol/L, rosuvastatin increased the phosphorylation of protein kinase B (Akt) and GSK-3β, concomitant with a higher Ca2+ load required to open the mPTP. Rosuvastatin postconditioning also significantly increased superoxide dismutase activity and reduced malondialdehyde and radical oxygen species level. LY294002, phosphatidylinositol-3-kinase (PI3K) inhibitors, abolished these protective effects of rosuvastatin postconditioning. CONCLUSION: Rosuvastatin prevents myocardial ischemia-reperfusion injury by inducing phosphorylation of PI3K-Akt and GSK-3β, preventing oxidative stress and subsequent inhibition of mPTP opening.
SN - 1755-5922
UR - https://www.unboundmedicine.com/medline/citation/27580017/Rosuvastatin_postconditioning_protects_isolated_hearts_against_ischemia_reperfusion_injury:_The_role_of_radical_oxygen_species_PI3K_Akt_GSK_3β_pathway_and_mitochondrial_permeability_transition_pore_
L2 - https://doi.org/10.1111/1755-5922.12225
DB - PRIME
DP - Unbound Medicine
ER -